Lee F. Allen
2017 - Dova Pharmaceuticals
In 2017, Lee F. Allen earned a total compensation of $2M as Chief Medical Officer at Dova Pharmaceuticals.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $160,000 |
| Option Awards | $1,497,983 |
| Salary | $285,221 |
| Other | $5,334 |
| Total | $1,968,538 |
Allen received $1.5M in option awards, accounting for 76% of the total pay in 2017.
Allen also received $20K in bonus, $160K in non-equity incentive plan, $285.2K in salary and $5.3K in other compensation.
Rankings
In 2017, Lee F. Allen's compensation ranked 5,578th out of 14,666 executives tracked by ExecPay. In other words, Allen earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,578 out of 14,666 | 62nd |
Division Manufacturing | 2,019 out of 5,768 | 65th |
Major group Chemicals And Allied Products | 622 out of 2,074 | 70th |
Industry group Drugs | 478 out of 1,730 | 72nd |
Industry Pharmaceutical Preparations | 375 out of 1,329 | 72nd |
Source: SEC filing on April 27, 2018.
Allen's colleagues
We found two more compensation records of executives who worked with Lee F. Allen at Dova Pharmaceuticals in 2017.